Visualizing transient events in amino-terminal autoprocessing of HIV-1 protease

Nature

Volumn 455, Issue 7213, 2008, Pages 693-696

  Tang, Chun ^a,b   Louis, John M ^a   Aniana, Annie ^a   Suh, Jeong Yong ^a   Clore, G Marius ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; PROTEINASE;

ENZYME ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS; PROTEIN; VIRUS;

AMINO TERMINAL SEQUENCE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRECURSOR; PRIORITY JOURNAL; PROTEIN DEGRADATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 53349152834     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature07342     Document Type: Article

References (40)

1. Louis, J. M., Weber, I. T., Tozser, J., Clore, G. M. & Gronenborn, A. M. HIV-1 protease: maturation, enzyme specificity, and drug resistance. Adv. Pharmacol. 49, 111-146 (2000).
2. Louis, J. M., Ishima, R., Torchia, D. A. & Weber, I. T. HIV-1 protease: structure, dynamics and inhibition. Adv. Pharmacol. 55, 261-298 (2007).
3. Wlodawer, A. & Erikson, J. Structure-based inhibitors of HIV-1 protease. Annu. Rev. Biochem. 62, 543-585 (1993).
4. Wlodawer, A. & Vondrasek, J. Inhibitors of HIV-1 protease: a major success of structure-assisted drug design. Annu. Rev. Biophys. Biomol. Struct. 27, 249-284 (1998).
5. Ishima, R., Torchia, D. A., Lynch, S. M., Gronenborn, A. M. & Louis, J. M. Solution structure of the mature HIV-1 protease monomer: insight into the tertiary fold and stability of a precursor. J. Biol. Chem. 278, 43311-43319 (2003).
6. Miller, M. et al. Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. Science 246, 1149-1152 (1989).
7. Louis, J. M., Nashed, N. T., Parris, K. D., Kimmel, A. R. & Jerina, D. M. Kinetics and mechanism of autoprocessing of human immunodeficiency virus type 1 protease from an analog of the Gag-Pol polyprotein. Proc. Natl Acad. Sci. USA 91, 7970-7974 (1994).
8. Co, E. et al. Proteolytic processing mechanisms of a miniprecursor of the aspartic protease of human immunodeficiency virus type 1. Biochemistry 33, 1248-1254 (1994).
9. Louis, J. M., Wondrak, E. M., Kimmel, A. R., Wingfield, P. T. & Nashed, N. T. Proteolytic processing of HIV-1 protease precursor, kinetics and mechanism. J. Biol. Chem. 274, 23437-23442 (1999).
10. Louis, J. M., Clore, G. M. & Gronenborn, A. M. Autoprocessing of HIV-1 protease is tightly coupled to protein folding. Nature Struct. Biol. 6, 868-874 (1999).
11. Pettit, S. C., Everitt, L. E., Choudhury, S., Dunn, B. M. & Kaplan, A. H. Initial cleavage of the human immunodeficiency virus type 1 GagPol precursor by its activated protease occurs by an intramolecular mechanism. J. Virol. 78, 8477-8485 (2004).
12. Ishima, R., Torchia, D. A. & Louis, J. M. Mutational and structural studies aimed at characterizing the monomer of HIV-1 protease and its precursor. J. Biol. Chem. 282, 17190-17199 (2007).
13. Iwahara, J. & Clore, G. M. Detecting transient intermediates in macromolecular binding by paramagnetic NMR. Nature 440, 1227-1230 (2006).
14. Tang, C., Iwahara, J. & Clore, G. M. Visualization of transient encounter complexes in protein-protein association. Nature 444, 383-386 (2006).
15. Volkov, A. N., Worall, J. A., Holtzmann, E. & Ubbink, M. Solution structure and dynamics of the complex between cytochrome c and cytochrome c peroxidase determined by paramagnetic NMR. Proc. Natl Acad. Sci. USA 103, 18945-18950 (2006).
16. Tang, C., Schwieters, C. D. & Clore, G. M. Open-to-closed transition in apo maltose-binding protein observed by paramagnetic NMR. Nature 449, 1078-1082 (2007).
17. Tessmer, U. & Kräusslich, H.-G. Cleavage of human immunodeficiency virus type 1 proteinase from the N-terminally adjacent p6* protein is essential for efficient Gag polyprotein processing and viral infectivity. J. Virol. 72, 3459-3463 (1998).
18. Ludwig, C., Leiherer, A. & Wagner, G. Importance of protease cleavage sites within and flanking human immunodeficiency virus type 1 transframe protein p6* for spatiotemporal regulation of protease activation. J. Virol. 82, 4573-4584 (2008).
19. Wondrak, E. M., Nashed, N. T., Haber, M. T., Jerina, D. M. & Louis, J. M. A transient precursor of the HIV-1 protease: isolation, characterization and kinetics of maturation. J. Biol. Chem. 271, 4477-4481 (1996).
20. Cherry, E. et al. Characterization of human immunodeficiency virus type-1 (HIV-1) particles that express protease-reverse transcriptase fusion proteins. J. Mol. Biol. 284, 43-56 (1998).
21. 1H transverse paramagnetic relaxation enhancement measurements on macromolecules. J. Magn. Reson. 184, 185-195 (2007).
22. Schwieters, C. D., Kuszewski, J. & Clore, G. M. Using Xplor-NIH for NMR molecular structure determination. Prog. Nucl. Magn. Reson. Spectrosc. 48, 47-62 (2006).
23. 1H paramagnetic relaxation enhancement data arising from a flexible paramagnetic group attached to a macromolecule. J. Am. Chem. Soc. 126, 5879-5896 (2004).
24. Spinelli, S., Liu, Q. Z., Alzari, P. M., Hirel, P. H. & Poljak, R. J. The three-dimensional structure of the aspartyl protease from the HIV-1 isolate BRU. Biochimie 73, 1391-1396 (1991).
25. Schwieters, C. D. & Clore, G. M. Reweighted atomic densities to represent ensembles of NMR structures. J. Biomol. NMR 23, 221-225 (2002).
26. Wondrak, E. M. & Louis, J. M. Influence of flanking sequences on the dimer stability of human immunodeficiency virus type 1 protease. Biochemistry 35, 12957-12962 (1996).
27. Mahalingam, B. et al. Crystal structures of HIV protease V82A and L90M mutants reveal changes in the indinavir-binding site. Eur. J. Biochem. 271, 1516-1524 (2004).
28. Altieri, A. S., Hinton, D. P. & Byrd, R. A. Association of biomolecular systems via pulsed field gradient NMR self-diffusion measurements. J. Am. Chem. Soc. 117, 7566-7567 (1995).
29. Chou, J. J., Baber, J. L. & Bax, A. Characterization of phospholipid mixed micelles by translational diffusion. J. Biomol. NMR 29, 299-308 (2004).
30. 2O in protein NMR: application to sensitivity enhancement and NOE measurements. J. Am. Chem. Soc. 115, 12593-12594 (1993).
31. Clore, G. M. & Gronenborn, A. M. Two-, three- and four-dimensional NMR methods for obtaining larger and more precise three-dimensional structures of proteins in solution. Annu. Rev. Biophys. Biophys. Chem. 20, 29-63 (1991).
32. Clore, G. M. & Gronenborn, A. M. Multidimensional heteronuclear nuclear magnetic resonance of proteins. Methods Enzymol. 239, 349-363 (1994).
33. Grzesiek, S., Stahl, S. J., Wingfield, P. T. & Bax, A. The CD4 determinant of downregulation by HIV-1 Nef directly binds to Nef: mapping of the Nef binding surface by NMR. Biochemistry 35, 10256-10261 (1996).
34. 13C chemical-shift data. J. Biomol. NMR 4, 171-180 (1994).
35. Shen, Y. et al. Consistent blind protein structure generation from NMR chemical shift data. Proc. Natl Acad. Sci. USA 105, 4685-4690 (2008).
36. Katoh, E. et al. A solution NMR study of the binding kinetics and internal dynamics of an HIV-1 protease-substrate complex. Protein Sci. 12, 1376-1385 (2003).
37. 1 rotamer populations and angles of mobile surface side chains are accurately predicted by a torsion angle database potential of mean force. J. Am. Chem. Soc. 124, 2866-2867 (2002).
38. Kuszewski, J., Gronenborn, A. M. & Clore, G. M. Improving the packing and accuracy of NMR structures with a pseudopotential for the radius of gyration. J. Am. Chem. Soc. 121, 2337-2338 (1999).
39. Tang, C., Ghirlando, R. & Clore, G. M. Visualization of transient ultra-weak protein self-association in solution using paramagnetic relaxation enhancement. J. Am. Chem. Soc. 130, 4048-4056 (2008).
40. Kim, Y. C., Tang, C., Clore, G. M. & Hummer, G. Replica exchange simulations of transient encounter complexes in protein-protein association. Proc. Natl Acad. Sci. USA 105, 12855-12860 (2008).